Optometrists in Belcourt, ND Accepting Medicare
3 Optometrists found. Showing 1 - 3
 Dr. Glen T Cahill, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1300 Hospital Road, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-2507 |
 Miss Ann Elizabeth Benavidez, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1300 Hospital Loop, Belcourt, ND 58316 Phone: 701-477-6111 Fax: 701-477-2500 |
Dr. Terry James Schleisman, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Way, Box 160, Belcourt, ND 58316 Phone: 701-477-6111 |
News Archive
Study: IL-2 monotherapy not effective as maintenance therapy for acute myeloid leukemia
EpiCept Corporation announced today the publication of a new meta-analysis which concluded that interleukin-2 (IL-2) monotherapy is not effective as a maintenance therapy for acute myeloid leukemia (AML) patients in first complete remission. These results were published in the July 7, 2011 edition of Blood, a leading scientific journal in hematology.
Pitt and Drexel researchers team up with NIH to investigate persistence of Ebola virus in wastewater
The historic outbreak of Ebola virus disease in West Africa that began in March 2014 and has killed more than 11,000 people since, has raised new questions about the resilience of the virus and tested scientists' understanding of how to contain it. The latest discovery by a group of microbial risk-assessment and virology researchers suggests that the procedures for disposal of Ebola-contaminated liquid waste might underestimate the virus' ability to survive in wastewater.
Researchers reveal possible drug targets to combat anthrax
A trawl of the genome of the deadly bacterium Bacillus anthracis has revealed a clutch of targets for new drugs to combat an epidemic of anthrax or a biological weapons attack.
New York Times highlights shortfalls in transplant patient immunosuppressive drug coverage
Today's New York Times article by Kevin Sack, "Plan for Kidney Drugs Spurs Division," illustrates an internal renal community reimbursement debate that may result in kidney patients continuing to be deprived of their life-saving immunosuppressive medications beyond the current 36-month Medicare program limit.
› Verified 5 days ago